Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -1.32K%
March 31, 2026 -993.2%
December 31, 2025 -1.53K%
September 30, 2025 -443.0%
June 30, 2025 -868.3%
March 31, 2025 -1.04K%
December 31, 2024 -1.05K%
September 30, 2024 -174.6%
June 30, 2024 -397.2%
March 31, 2024 -706.5%
December 31, 2023 -8.49%
September 30, 2023 -315.2%
June 30, 2023 -1.58K%
March 31, 2023 -1.11K%
December 31, 2022 -356.4%
September 30, 2022 -104.9%
June 30, 2022 -1.34K%
March 31, 2022 -1.29K%
Date Value
December 31, 2021 -1.52K%
September 30, 2021 -1.27K%
June 30, 2021 -995.7%
March 31, 2021 -1.62K%
December 31, 2020 -860.6%
September 30, 2020 -735.6%
June 30, 2020 -565.5%
March 31, 2020 -1.09K%
December 31, 2019 -1.75K%
September 30, 2019 -2.35K%
June 30, 2019 -4.93K%
March 31, 2019 -2.16K%
December 31, 2018 -1.39K%
September 30, 2018 -1.85K%
June 30, 2018 -849.2%
March 31, 2018 -2.70K%
December 31, 2017 -2.30K%
September 30, 2017 -2.66K%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. 16.45%
Xeris Biopharma Holdings, Inc. -33.77%
Alumis, Inc. -8.56K%
ANI Pharmaceuticals, Inc. 8.65%
Veru, Inc. --